The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update

Frontiers in Endocrinology

Volumn 7, Issue , 2016, Pages

  Annane, Djillali ^a,b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

cytokines; hypothalamic pituitary adrenal axis; nitric oxide; sepsis; stress response

Indexed keywords

EID: 84994834198     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00070     Document Type: Review

References (89)

1. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis (2005) 41(Suppl 7):S490–7.10.1086/43200316237652
2. Iwashyna TJ Ely EW Smith DM Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA (2010) 304:1787–94.10.1001/jama.2010.155320978258
3. Annane D Sharshar T. Cognitive decline after sepsis. Lancet Respir Med (2015) 3:61–9.10.1016/S2213-2600(14)70246-225434614
4. Singer M Deutschman CS Seymour CW Shankar-Hari M Annane D Bauer M et al. The third international consensus definition for sepsis and septic shock (sepsis 3). JAMA (2016) 315:1–10.10.1001/jama.2016.0287
5. Selye H. A syndrome produced by diverse nocuous agents. Nature (1936) 138:32.10.1038/138032a0
6. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 322(20):1351–62.
7. Annane D Bellissant E Cavaillon JM. Septic shock. Lancet (2005) 365:63–78.10.1016/S0140-6736(04)17667-815639681
8. Kenney MJ Ganta CK. Autonomic nervous system and immune system interactions. Compr Physiol (2014) 4:1177–200.10.1002/cphy.c13005124944034
9. Borovikova LV Ivanova S Zhang M Yang H Botchkina GI Watkins LR et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 405:458–62.10.1038/3501307010839541
10. Karanth S Lyson K McCann SM. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus. Neuroimmunomodulation (1999) 6:168–74.10.1159/00002637810213914
11. McCann SM Kimura M Karanth S Yu WH Mastronardi CA Rettori V. The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann NY Acad Sci (2000) 917:4–18.10.1111/j.1749-6632.2000.tb05368.x11268367
12. Koenig JI. Presence of cytokines in the hypothalamic-pituitary axis. Prog Neuroendocrinoimmunol (1991) 4:143–53.
13. Deng X Wang X Andersson R. Endothelial barrier resistance in multiple organs after septic and nonseptic challenges in the rat. J Appl Physiol (1985) 78:2052–61.
14. Papadopoulos MC Lamb FJ Moss RF Davies DC Tighe D Bennett ED. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond) (1999) 96:461–6.10.1042/cs096046110209077
15. Sharshar T Carlier R Bernard F Guidoux C Brouland JP Nardi O et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 33:798–806.10.1007/s00134-007-0598-y17377766
16. Stubbs DJ Yamamoto AK Menon DK. Imaging in sepsis-associated encephalopathy – insights and opportunities. Nat Rev Neurol (2013) 9:551–61.10.1038/nrneurol.2013.177
17. Gasque P Singhrao SK Neal JW Gotze O Morgan BP. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol (1997) 150:31–41.9006319
18. van Dam AM Brouns M Louisse S Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res (1992) 588:291–6.10.1016/0006-8993(92)91588-61393581
19. Gatti S Bartfai T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res (1993) 624:291–4.10.1016/0006-8993(93)90090-A8252403
20. Sharshar T Gray F Lorin de la Grandmaison G Hopkinson NS Ross E Dorandeu A et al. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet (2003) 362:1799–805.10.1016/S0140-6736(03)14899-4
21. Dantzer R O’Connor JC Freund GG Johnson RW Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 9:46–56.10.1038/nrn229718073775
22. Bernardini R Kamilaris TC Calogero AE Johnson EO Gomez MT Gold PW et al. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology (1990) 126:2876–81.10.1210/endo-126-6-2876
23. Sapolsky R Rivier C Yamamoto G Plotsky P Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (1987) 238:522–4.10.1126/science.28216212821621
24. Bethin KE Vogt SK Muglia LJ. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci U S A (2000) 97:9317–22.10.1073/pnas.97.16.931710922080
25. Matsuwaki T Eskilsson A Kugelberg U Jönsson JI Blomqvist A. Interleukin-1β induced activation of the hypothalamus-pituitary-adrenal axis is dependent on interleukin-1 receptors on non-hematopoietic cells. Brain Behav Immun (2014) 40:166–73.10.1016/j.bbi.2014.03.015
26. Jaattela M Ilvesmaki V Voutilainen R Stenman UH Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology (1991) 128:623–9.10.1210/endo-128-1-6231702707
27. Darling G Goldstein DS Stull R Gorschboth CM Norton JA. Tumor necrosis factor: immune endocrine interaction. Surgery (1989) 106:1155–60.2555929
28. Mikhaylova IV Kuulasmaa T Jääskeläinen J Voutilainen R. Tumor necrosis factor-alpha regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCI-H295R. Endocrinology (2007) 148:386–92.10.1210/en.2006-072617038555
29. Jaattela M Carpen O Stenman UH Saksela E. Regulation of ACTH induced steroidogenesis in human fetal adrenals by rTNF. Mol Cell Endocrinol (1990) 68:R31–6.10.1016/0303-7207(90)90196-F
30. Engström L Rosén K Angel A Fyrberg A Mackerlova L Konsman JP et al. Systemic immune challenge activates an intrinsically regulated local inflammatory circuit in the adrenal gland. Endocrinology (2008) 149:1436–50.10.1210/en.2007-145618174279
31. Bornstein SR Schumann RR Rettori V McCann SM Zacharowski K. Toll-like receptor 2 and toll-like receptor 4 expression in human adrenals. Horm Metab Res (2004) 36:470–3.10.1055/s-2004-82575015305230
32. Bornstein SR Zacharowski P Schumann RR Barthel A Tran N Papewalis C et al. Impaired adrenal stress response in toll-like receptor 2-deficient mice. Proc Natl Acad Sci U S A (2004) 101:16695–700.10.1073/pnas.040755010115546996
33. Zacharowski K Zacharowski PA Koch A Baban A Tran N Berkels R et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci U S A (2006) 103:6392–7.10.1073/pnas.060152710316606831
34. Kanczkowski W Alexaki VI Tran N Großklaus S Zacharowski K Martinez A et al. Hypothalamo-pituitary and immune-dependent adrenal regulation during systemic inflammation. Proc Natl Acad Sci U S A (2013) 110:14801–6.10.1073/pnas.131394511023959899
35. Jung B Nougaret S Chanques G Mercier G Cisse M Aufort S et al. The absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography study of 239 patients. Anesthesiology (2011) 115:334–43.10.1097/ALN.0b013e318225cfd721720239
36. Waterhouse R. A case of suprarenal apoplexy. Lancet (1911) 1:576.
37. Friderichsen C. Nebennierenapoplexie bei kleinen Kindern. Jahrb f Kinderheilk (1918) 87:109.
38. Sharshar T Annane D Lorin de la Grandmaison G Brouland JP Hopkinson NS Gray F. The neuropathology of septic shock. Brain Pathol (2004) 14:21–33.10.1111/j.1750-3639.2004.tb00494.x14997934
39. Mélik Parsadaniantz S Levin N Lenoir V Roberts JL Kerdelhué B. Human interleukin 1 beta: corticotropin releasing factor and ACTH release and gene expression in the male rat: in vivo and in vitro studies. J Neurosci Res (1994) 37:675–82.10.1002/jnr.4903706027519272
40. Parsadaniantz SM Batsché E Gegout-Pottie P Terlain B Gillet P Netter P et al. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone. Neuroendocrinology (1997) 65:53–63.10.1159/000127164
41. Wong ML Rettori V al-Shekhlee A Bongiorno PB Canteros G McCann SM et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med (1996) 2:581–4.10.1038/nm0596-5818616720
42. Brunetti L Volpe AR Ragazzoni E Preziosi P Vacca M. Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. Life Sci (1996) 58:L373–7.10.1016/0024-3205(96)00238-X8649215
43. Polito A Sonneville R Guidoux C Barrett L Viltart O Mattot V et al. Changes in CRH and ACTH synthesis during experimental and human septic shock. PLoS One (2011) 6(11):e25905.10.1371/journal.pone.0025905
44. Bornstein SM. Predisposing factors for adrenal insufficiency. N Engl J Med (2009) 360:2328–39.10.1056/NEJMra0804635
45. Vuong C Van Uum SH O’Dell LE Lutfy K Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev (2010) 31:98–132.10.1210/er.2009-000919903933
46. Cortés-Puch I Hicks CW Sun J Solomon SB Eichacker PQ Sweeney DA et al. Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia. Am J Physiol Endocrinol Metab (2014) 307:E994–1008.10.1152/ajpendo.00345.201425294215
47. Boonen E Vervenne H Meersseman P Andrew R Mortier L Declercq PE et al. Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 368:1477–88.10.1056/NEJMoa121496923506003
48. Annane D Maxime V Ibrahim F Alvarez JC Abe E Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med (2006) 174:1319–26.10.1164/rccm.200509-1369OC16973979
49. Polito A Lorin de la Grandmaison G Mansart A Louiset E Lefebvre H Sharshar T et al. Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals. Intensive Care Med (2010) 36:1852–8.10.1007/s00134-010-1987-1
50. Buss NA Gavins FN Cover PO Terron A Buckingham JC. Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex. FASEB J (2015) 29:2930–42.10.1096/fj.14-26837525818588
51. Wang N Weng W Breslow JL Tall AR. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem (1996) 271(35):21001–4.
52. Cai L Ji A de Beer FC Tannock LR van der Westhuyzen DR. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest (2008) 118:364–75.10.1172/JCI3153918064300
53. Gilibert S Galle-Treger L Moreau M Saint-Charles F Costa S Ballaire R et al. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice. J Immunol (2014) 193:817–26.10.4049/jimmunol.130316424935924
54. Harvey PW. Adrenocortical endocrine disruption. J Steroid Biochem Mol Biol (2016) 155:199–206.10.1016/j.jsbmb.2014.10.00925460300
55. Bruder EA Ball IM Ridi S Pickett W Hohl C. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev (2015) 1:CD010225.10.1002/1465185825568981
56. Tominaga T Fukata J Naito Y Nakai Y Funakoshi S Fujii N et al. Effects of corticostatin-I on rat adrenal cells in vitro. J Endocrinol (1990) 125:287–92.10.1677/joe.0.12502872165121
57. Beishuizen A Thijs LG Vermes I. Patterns of corticosteroid binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med (2000) 27:1584–91.10.1007/s001340101073
58. Pemberton PA Stein PE Pepys MB Potter JM Carrell RW. Hormone binding globulins undergo serpin conformational change in inflammation. Nature (1988) 336:257–8.10.1038/336257a03143075
59. Hammond GL Smith CL Paterson NA Sibbald WJ. A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab (1990) 71:34–9.10.1210/jcem-71-1-342370299
60. Rook G Baker R Walker B Honour J Jessop D Hernandez-Pando R et al. Local regulation of glucocorticoid activity in sites of inflammation. Insights from the study of tuberculosis. Ann N Y Acad Sci (2000) 917:913–22.10.1111/j.1749-6632.2000.tb05457.x
61. Stith RD McCallum RE. Down regulation of hepatic glucocorticoid receptors after endotoxin treatment. Infect Immun (1983) 40:613–21.6840856
62. Galigniana MD Piwien-Pilipuk G Assreuy J. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharmacol (1999) 55:317–23.9927624
63. Kamiyama K Matsuda N Yamamoto S Takano K Takano Y Yamazaki H et al. Modulation of glucocorticoid receptor expression, inflammation, and cell apoptosis in septic guinea pig lungs using methylprednisolone. Am J Physiol Lung Cell Mol Physiol (2008) 295:L998–1006.10.1152/ajplung.00459.2007
64. Kleiman A Hübner S Rodriguez Parkitna JM Neumann A Hofer S Weigand MA et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J (2012) 26:722–9.10.1096/fj.11-19211222042221
65. Liu J Haigh RM Jones CT. Enhancement of noradrenaline-induced inositol polyphosphate formation by glucocorticoids in rat vascular smooth muscle cells. J Endocrinol (1992) 133:405–11.10.1677/joe.0.13304051613441
66. Annane D Bellissant E Sebille V Lesieur O Mathieu B Raphael JC et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol (1998) 46:589–97.10.1046/j.1365-2125.1998.00833.x9862249
67. d’Emmanuele di Villa Bianca R Lippolis L Autore G Popolo A Marzocco S Sorrentino L et al. Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity. Br J Pharmacol (2003) 140:91–6.10.1038/sj.bjp.0705406
68. Goodwin JE Feng Y Velazquez H Sessa WC. Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A (2013) 110:306–11.10.1073/pnas.121020011023248291
69. Büchele GL Silva E Ospina-Tascón GA Vincent JL De Backer D. Effects of hydrocortisone on microcirculatory alterations in patients with septic shock. Crit Care Med (2009) 37:1341–7.10.1097/CCM.0b013e318198664719326575
70. Hafezi-Moghadam A Simoncini T Yang Z Limbourg FP Plumier JC Rebsamen MC et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 8:473–9.10.1038/nm0502-47311984591
71. Annane D Bellissant E Bollaert PE Briegel J Keh D Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev (2015) 12:CD002243.10.1002/14651858
72. van Leeuwen HJ van der Bruggen T van Asbeck BS Boereboom FT. Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock. Crit Care Med (2001) 29:1074–7.10.1097/00003246-200105000-0004111378624
73. Meduri GU Muthiah MP Carratu P Eltorky M Chrousos GP. Nuclear factor kappaB- and glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation (2005) 12:321–38.10.1159/000091126
74. Johannes T Mik EG Klingel K Dieterich HJ Unertl KE Ince C. Low-dose dexamethasone-supplemented fluid resuscitation reverses endotoxin-induced acute renal failure and prevents cortical microvascular hypoxia. Shock (2009) 31:521–8.10.1097/SHK.0b013e318188d198
75. Rinaldi S Adembri C Grechi S DE Gaudio R. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med (2006) 34:2334–9.10.1097/01.CCM.0000233872.04706.BB16850006
76. Laviolle B Annane D Fougerou C Bellissant E. Gluco- and mineralocorticoid biological effects of a 7-day treatment with low doses of hydrocortisone and fludrocortisone in septic shock. Intensive Care Med (2012) 38:1306–14.10.1007/s00134-012-2585-122584796
77. Forster C Burek M Romero IA Weksler B Couraud PO Drenckhahn D. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol (2008) 586:1937–49.10.1113/jphysiol.2007.146852
78. Kashiwamura Y Sano Y Abe M Shimizu F Haruki H Maeda T et al. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5. Neurochem Res (2011) 36:849–55.10.1007/s11064-011-0413-6
79. Loisa P Parviainen I Tenhunen J Hovilehto S Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care (2007) 11:R21.10.1186/cc569617306016
80. Annane D Cariou A Maxime V Azoulay E D’honneur G Timsit JF et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 303:341–8.10.1001/jama.2010.220103758
81. Lacomis D Giulani M van Cott A Kramer D. Acute myopathy of intensive care – clinical, electromyographic and pathologic aspects. Ann Neurol (1996) 40:645–54.10.1002/ana.410400415
82. Schakman O Kalista S Barbé C Loumaye A Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol (2013) 45:2163–72.10.1016/j.biocel.2013.05.03623806868
83. Schreiber MP Colantuoni E Bienvenu OJ Neufeld KJ Chen KF Shanholtz C et al. Corticosteroids and transition to delirium in patients with acute lung injury. Crit Care Med (2014) 42:1480–6.10.1097/CCM.000000000000024724589640
84. Wolters AE Veldhuijzen DS Zaal IJ Peelen LM van Dijk D Devlin JW et al. Systemic corticosteroids and transition to delirium in critically ill patients. Crit Care Med (2015) 43:e585–8.10.1097/CCM.000000000000130226427589
85. Annane D. Corticosteroids for severe sepsis: an evidence-based guide for physicians. Ann Intensive Care (2011) 1(1):7.10.1186/2110-5820-1-727154719
86. Moran JL Graham PL Rockliff S Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care (2010) 14:R134.10.1186/cc918220626892
87. Kalil AC Sun J. Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies. Intensive Care Med (2011) 37:420–9.10.1007/s00134-010-2121-021243334
88. Volbeda M Wetterslev J Gluud C Zijlstra JG van der Horst IC Keus F. Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med (2015) 41:1220–34.10.1007/s00134-015-3899-626100123
89. Dellinger RP Levy MM Rhodes A Annane D Gerlach H Opal SM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 39:165–228.10.1007/s00134-012-2769-823361625